Article de revue

Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccines

The immunogenicity of pertussis antigens in an acellular and a whole-cell triple antigen vaccine used for childhood immunisation was assessed in murine models after storage of vaccines below 0 degree C. Swiss outbred and Balb/c mice received DTPa or DTPw vaccine or placebo. Vaccines were stored at 2-8 degrees C (ideal), or at -3 degrees C for 24 h. Pre and post immunisation IgG responses to pertussis toxin (PT), filamentous haemagglutinin (FHA) and pertactin (PRN) were measured using enzyme immunoassays (EIA). In Balb/c mice, responses to pertactin after receiving adversely stored DTPa were significantly reduced (P = 0.005, difference in GMCs 145.9% [24.6-385.4%]). A reduction in GMC to pertactin was also seen in response to adversely stored DTPw (P = 0.190,224.1% [83.8-599.2%]). Outbred mice receiving adversely stored DTPa had lower IgG antibody responses to FHA than those receiving correctly stored vaccine (P = 0.002,522.2% [26.1-2155.6%]). Outbred mice also had a significantly lower response to FHA after administration of DTPw (P = 0.009,14.0% [3.8-51.9%]). Responses to DTPa in both strains generally were greater than those to DTPw. Storage of pertussis vaccines below 0 degree C appears to alter the immunogenicity of PRN and FHA. Further study is required to determine the effects of such storage on vaccine protective efficacy.

Langues

  • Anglais

Journal

Vaccine

Volume

25-26

Type

Article de revue

Catégories

  • Vaccins et dispositifs d'administration

Références sur le sujet

FREEZE-PREVENTION-POTENCY

TitreAuteurAnnéeTypeLangue
Assessing the potency and immunogenicity of inactivated poliovirus vaccine after exposure to freezing temperaturesAbhijeet Anand, Cynthia J. Snider, Dexiang Chen, Diana Kouiavskaia, Edmond F. Maes, Eric Stevens, Howard E. Gary Jr., Jacqueline Fournier-Caruana, Jessica A. White, Konstantin Chumakov, M. Steven Oberste, Marcus Estrada, William C. WeldonJournal articleAnglais
Cold chain study: danger of freezing vaccinesP. MilhommeJournal articleAnglais
Comparison of hepatitis B vaccine coverage and effectiveness among urban and rural Mongolian 2-year-oldsAnn Marie Kimball, Arslan Rinchin, J. Khulan, James S. Edstam, Nyamkhuu Dulmaa, Pagbajabyn NymadawaJournal articleAnglais
Effects of freezing on DPT and DPT-IPV vaccines, adsorbedA. Bell, D. Scheifele, R. DimayugaJournal articleAnglais, Français
Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problemsA. Galazka, F. van Loon, S. Cochi, V. DietzJournal articleAnglais
Hepatitis B vaccineArlene A. McLean, Raymond Shaw Jr.Journal articleAnglais
Hepatitis B vaccine in healthy hospital employeesR. Normand, R. Silberman, S. A. KlotzJournal articleAnglais
Performance and potency of tetanus toxoid: implications for eliminating neonatal tetanusF. van Loon, J. B. Milstien, J. Bennett, S. Cochi, V. DietzJournal articleAnglais
Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particlesDvorah Diminsky, Marian Gorecki, Neomi Moav, Yechezkel BarenholzJournal articleAnglais
Storage at -3 degrees C for 24 h alters the immunogenicity of pertussis vaccinesChristina Ann Boros, D. M. Roberton, M. Hanlon, Michael Steven GoldJournal articleAnglais

Ajouté par: Joseph Little

Ajouté le: 2023-06-29 12:58:55

Consultations: 1812